13D·WATCH Activist + Insider Intelligence Live feed Blog About Pricing
SCHEDULE 13D Filed 2026-04-10 Event 2026-04-10 Intent: UNCLEAR SEC 0001213900-26-042437 →

T3 Defense Inc. BiomX Inc. PHGE

Stake: 19.87% Shares: 1,300,000 CUSIP: 09090D509 Class: Common Stock, par value $0.0001 per share
AI Analyst Brief conf: low
T3 Defense Inc. files a Schedule 13D on BiomX (PHGE), a clinical-stage phage therapy biotech, with 1.3M shares — notable as the first activist filing on this issuer in 90 days and T3 Defense's first 13D/G on record, suggesting a new strategic relationship rather than a financial play; the defense-sector filer name against a biotech issuer raises questions about a potential pivot, partnership, or a

Item 4 — Purpose of Transaction

The shares of Common Stock were acquired by Water IO as consideration in connection with the sale of Zorronet to the Issuer, as described in Item 3 above. The Reporting Persons acquired the shares for investment purposes. The Reporting Persons may, from time to time, acquire additional shares of Common Stock in the open market, in privately negotiated transactions, or otherwise, or may dispose of all or a portion of the shares of Common Stock held by them, subject to applicable securities law restrictions, including any lock-up or registration requirements. The Reporting Persons may also engage in discussions with the Issuer's management, board of directors, or other stockholders regarding the Issuer's business, management, operations, strategy, or governance. Any such actions will depend upon a variety of factors, including the price and availability of the Common Stock, general market conditions, and other factors deemed relevant by the Reporting Persons. Except as described herein, the Reporting Persons do not currently have any plans or proposals that would relate to or result in any of the actions enumerated in paragraphs (a) through (j) of Item 4 of Schedule 13D.

Cross-References

Insider Activity (last 365d)
0 transactions
0 buys · 0 sales · 0 awards/exercises
Issuer Cluster
7 13D/G filings on this issuer
6 other filings besides this one
Filer Track Record
1 filings by this filer
0 other filings in the data moat
Short Interest · settle 2026-07-15
DTC 1.00
190,323 shares short · -79.5% vs prior

Post-Filing Returns · since 2026-04-10 on PHGE

+1 day
-9.0%
+5 days
-33.2%
+30 days
-89.6%
+60 days
-89.6%
+90 days
-90.3%
+180 days

Anchor price 2.89 on closest trading day on/after 2026-04-10. Source: Yahoo Finance daily adj_close (split + dividend adjusted).

Other 13D/G Filings on BiomX Inc.

FiledFormFilerStakeShares
2026-06-16 SCHEDULE 13D/A Flynn James E 4.70% 266,424 view →
2026-05-28 SCHEDULE 13D/A Flynn James E 8.09% 444,703 view →
2025-03-03 SCHEDULE Flynn James E 9.99% 15,558,445 view →
2024-07-11 SC Flynn James E view →
2024-05-30 SC Flynn James E view →
2023-03-17 SC OrbiMed Israel BioFund GP Limited Partnership view →

Want this depth on every filing the moment it hits SEC EDGAR?

Full feed access · API · daily intelligence brief · custom alerts. From $49/mo.

See pricing →